About: Kineta Inc
Profile:
Posts by Kineta Inc:
- Kineta to Present at the H.C. Wainwright Bioconnect Virtual Conference (January 11, 2022 - Kineta Press Release)
- Kineta Presented New Preclinical Data on its Anti-CD27 Agonist Antibody Program at the ESMO Immuno-oncology Congress 2021 (December 17, 2021 - Kineta Press Release)
- Kineta Presents Phase 1/2 Clinical Trial Design of KVA12.1 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting (November 29, 2021 - Kineta Press Release)
- Kineta Presented Compelling Preclinical Data on its New CD27 Antibody Program at the 2021 SITC Annual Meeting (November 16, 2021 - Kineta Press Release)
- Kineta Presents Preclinical Data on its New CD27 Program at the AACR Conference on Tumor Immunology and Immunotherapy (October 7, 2021 - Kineta Press Release)
- Kineta Announces Poster Presentation at the 2021 American Association for Cancer Research Conference on Tumor Immunology and Immunotherapy (September 28, 2021 - Kineta Press Release)
- Kineta Announces Participation at H.C. Wainwright 23rd Annual Global Investment Conference (September 25, 2021 - Kineta Press Release)
- Kineta Announces Patent Issuance of U.S. Patent for Composition of Matter of KCP506 (August 10, 2021 - Kineta Press Release)
- Research Associate, Immuno-oncology (August 8, 2021 - Current Openings)
- Scientist, Immuno-oncology (August 8, 2021 - Current Openings)